jak inhibitors
| 5 min read
Jeremy Gale leads Pfizer’s inflammation & immunology research program to develop new therapies for moderate to severe inflammatory bowel disease.
Page 1 of 1 - 1 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Enhancing bioanalytical studies with centralized data management
Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Supercharging cell line development and engineering with automated single cell sorting
Researchers can enhance efficiency, yield, and consistency in clonal cell line development with specialized tools.
